Policy Briefings

Evotec Wins Up to $10M BioMaP Contract to Advance Ebola and SUDV Antibody Production

Pyramid Pharma Services Signs Five-Year Commercial Supply Agreement for siRNA Injectable Therapy

ESTEVE CDMO Expands Celrà Facility With 3,000 sqm Unit and New Spray Drying Capacity

LGM Pharma Invests $9 Million to Expand U.S. CDMO Manufacturing Capacity

BGF Invests £15 Million in Seda to Scale CRDMO Capabilities

Curia Expands Glasgow Facility with New Fill-Finish Line

SK pharmteco Commits $100 Million to Expand Viral Vector CDMO Capabilities

PolyPeptide Expands Credit Facility to €200 Million to Support Growth Strategy

Evotec and BMS Move CELMoD Candidate into Phase 1 Clinical Study

Touchlight Launches EnClose Cell-free dbDNA Synthesis Kit with NEB Collaboration

HLB Pep Signs CDMO Contract with Reprocell for Neoantigen Peptide Supply

Lupin Manufacturing Solutions Expands Dabhasa Facility to Scale Peptide Platform

Almac Sciences Expands API Services with cGMP Flow Hydrogenation Technology

Cellipont Bioservices Partners with BobcatBio for Phase I Manufacturing

Apertura Gene Therapy Partners with Viralgen

OXB Signs Five-Year Licensing Agreement with VVMF for Viral Vector Platforms

ValGenesis Deploys e-Logbook at LOTTE Biologics to Support Digital QC Operations

Celltrion Signs KRW 294.9 Billion($221M) CMO Deal for Three-Year Drug Substance Supply